DOCSLIB.ORG

Printmgr File

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Printmgr File GOLDMAN SACHS VARIABLE INSURANCE TRUST CORE FIXED INCOME FUND Schedule of Investments March 31, 2021 (Unaudited) Principal Interest Maturity Principal Interest Maturity Amount Rate Date Value Amount Rate Date Value Corporate Bonds – 37.2% Corporate Bonds – (continued) Automobiles & Components(a) – 0.1% Banks – (continued) General Motors Co. Fifth Third Bancorp(a) $ 5.400% 10/02/2023 $ 55,419 50,000 $ 30,000 2.375% 01/28/2025 $ 31,288 25,000 4.000 04/01/2025 27,236 Gazprom PJSC 82,655 240,000 4.950 03/23/2027 262,275 Banks – 9.4% GE Capital International Funding Co. Unlimited Co.(a) Ally Financial, Inc.(a) 200,000 3.373 11/15/2025 216,732 25,000 1.450 10/02/2023 25,371 General Motors Financial Co., Inc.(a) American Express Co.(a) 25,000 4.300 07/13/2025 27,494 20,000 2.500 07/30/2024 21,138 125,000 2.350 01/08/2031 119,409 25,000 3.625 12/05/2024 27,279 HSBC Holdings plc(a)(b) American Express Co. Series C(a)(b) (SOFR + 1.54%), (3 Mo. LIBOR + 3.29%), 200,000 1.645 04/18/2026 200,191 40,000 3.469 06/15/2021 39,750 Huntington Bancshares, Inc.(a) Avolon Holdings Funding Ltd.(a)(c) 50,000 4.000 05/15/2025 55,416 25,000 3.950 07/01/2024 26,130 ING Groep NV(a)(b)(c) 100,000 2.875 02/15/2025 100,086 (US Treasury Yield Curve Rate 25,000 4.250 04/15/2026 26,154 T-Note Constant Maturity 1 Yr. + Banco Santander SA 1.10%), 200,000 2.746 05/28/2025 209,214 200,000 1.400 07/01/2026 198,999 Bank of America Corp. Intercontinental Exchange, Inc.(a) 75,000 4.125 01/22/2024 81,975 50,000 3.000 06/15/2050 46,300 65,000 4.200 08/26/2024 71,655 JPMorgan Chase & Co.(a) 45,000 3.248(a) 10/21/2027 48,388 (3 Mo. LIBOR + 0.73%), (3 Mo. LIBOR + 1.58%), 25,000 3.559(b) 04/23/2024 26,492 75,000 3.824(a)(b) 01/20/2028 82,526 (3 Mo. LIBOR + 0.89%), (3 Mo. LIBOR + 1.37%), 25,000 3.797(b) 07/23/2024 26,775 25,000 3.593(a)(b) 07/21/2028 27,163 (3 Mo. LIBOR + 1.00%), (3 Mo. LIBOR + 1.04%), 50,000 4.023(b) 12/05/2024 54,252 85,000 3.419(a)(b) 12/20/2028 91,132 (SOFR + 1.16%), (3 Mo. LIBOR + 1.31%), 125,000 2.301(b) 10/15/2025 130,334 50,000 4.271(a)(b) 07/23/2029 56,368 (3 Mo. LIBOR + 1.25%), (3 Mo. LIBOR + 1.19%), 100,000 3.960(b) 01/29/2027 110,555 50,000 2.884(a)(b) 10/22/2030 51,404 15,000 3.625 12/01/2027 16,293 (SOFR + 2.15%), (3 Mo. LIBOR + 1.34%), 175,000 2.592(a)(b) 04/29/2031 174,448 75,000 3.782(b) 02/01/2028 82,719 (SOFR + 1.53%), (3 Mo. LIBOR + 0.95%), 50,000 1.898(a)(b) 07/23/2031 47,036 45,000 3.509(b) 01/23/2029 48,731 Bank of America Corp. Series L(a) (SOFR + 3.79%), 25,000 4.183 11/25/2027 27,810 25,000 4.493(b) 03/24/2031 28,838 Barclays plc(a)(b) (SOFR + 2.04%), (SOFR + 2.71%), 25,000 2.522(b) 04/22/2031 24,921 200,000 2.852 05/07/2026 209,195 (SOFR + 2.52%), BNP Paribas SA(c) 25,000 2.956(b) 05/13/2031 25,445 200,000 3.375 01/09/2025 214,674 JPMorgan Chase & Co. Series HH(a)(b) (SOFR + 1.00%), (SOFR + 3.13%), 200,000 1.323(a)(b) 01/13/2027 195,783 100,000 4.600 02/01/2025 101,039 Capital One Financial Corp. JPMorgan Chase & Co. Series Z(a)(b) 25,000 3.500 06/15/2023 26,591 (3 Mo. LIBOR + 3.80%), 45,000 3.300(a) 10/30/2024 48,522 85,000 4.005 05/01/2021 85,053 Citigroup, Inc. Macquarie Bank Ltd.(a)(b)(c) 220,000 3.400 05/01/2026 238,984 (US Treasury Yield Curve Rate 150,000 4.450 09/29/2027 168,704 T-Note Constant Maturity 5 Yr. + 25,000 4.125 07/25/2028 27,593 1.70%), (SOFR + 1.42%), 200,000 3.052 03/03/2036 191,466 75,000 2.976(a)(b) 11/05/2030 77,570 Macquarie Group Ltd.(a)(b)(c) Credit Suisse Group AG (SOFR + 1.07%), 250,000 4.550 04/17/2026 279,870 50,000 1.340 01/12/2027 49,052 Deutsche Bank AG(a)(b) (SOFR + 2.16%), 150,000 2.222 09/18/2024 153,766 Discover Financial Services(a) 75,000 3.750 03/04/2025 81,203 GOLDMAN SACHS VARIABLE INSURANCE TRUST CORE FIXED INCOME FUND Schedule of Investments (continued) March 31, 2021 (Unaudited) Principal Interest Maturity Principal Interest Maturity Amount Rate Date Value Amount Rate Date Value Corporate Bonds – (continued) Corporate Bonds – (continued) Banks – (continued) Capital Goods(a) – (continued) Morgan Stanley General Electric Co. (3 Mo. LIBOR + 1.40%), $ 25,000 3.450% 05/01/2027 $ 27,150 $ 50,000 1.618%(a)(b) 10/24/2023 $ 50,892 25,000 3.625 05/01/2030 26,913 (3 Mo. LIBOR + 0.85%), 25,000 4.250 05/01/2040 27,465 25,000 3.737(a)(b) 04/24/2024 26,568 50,000 4.350 05/01/2050 55,550 225,000 3.700(a) 10/23/2024 246,460 Masco Corp. (SOFR + 1.15%), 50,000 1.500 02/15/2028 48,095 75,000 2.720(a)(b) 07/22/2025 79,100 Northrop Grumman Corp. 25,000 3.625(a) 01/20/2027 27,450 50,000 2.930 01/15/2025 53,242 50,000 3.950 04/23/2027 55,182 75,000 3.250 01/15/2028 80,325 (3 Mo. LIBOR + 1.63%), 25,000 4.750 06/01/2043 30,191 25,000 4.431(a)(b) 01/23/2030 28,627 50,000 5.250 05/01/2050 65,190 (SOFR + 1.14%), Otis Worldwide Corp. 300,000 2.699(a)(b) 01/22/2031 304,320 25,000 2.293 04/05/2027 25,665 (SOFR + 3.12%), 150,000 2.565 02/15/2030 151,018 50,000 3.622(a)(b) 04/01/2031 54,211 Raytheon Technologies Corp. (SOFR + 1.03%), 50,000 3.950 08/16/2025 55,569 75,000 1.794(a)(b) 02/13/2032 70,017 50,000 4.125 11/16/2028 56,290 Morgan Stanley Series F(a) 25,000 4.050 05/04/2047 27,788 25,000 3.875 04/29/2024 27,308 Roper Technologies, Inc. Natwest Group plc 50,000 4.200 09/15/2028 56,361 200,000 3.875 09/12/2023 214,481 Stanley Black & Decker, Inc. NTT Finance Corp.(a)(c) 50,000 4.250 11/15/2028 57,334 200,000 2.065 04/03/2031 197,386 1,668,545 (a)(c) Nuveen LLC Commercial & Professional Services(a) – 0.6% 25,000 4.000 11/01/2028 28,154 CoStar Group, Inc. (c) Raymond James Financial, Inc.(a) 100,000 2.800 07/15/2030 97,359 25,000 4.650 04/01/2030 29,187 IHS Markit Ltd. Standard Chartered plc(a)(b)(c) 75,000 3.625 05/01/2024 80,625 (3 Mo. LIBOR + 1.15%), 75,000 4.250 05/01/2029 84,281 200,000 4.247 01/20/2023 205,538 Republic Services, Inc. Wells Fargo & Co. 75,000 2.500 08/15/2024 78,949 25,000 3.750(a) 01/24/2024 27,033 100,000 1.750 02/15/2032 92,979 175,000 3.000 10/23/2026 187,242 Waste Management, Inc. 50,000 4.300 07/22/2027 56,530 50,000 1.150 03/15/2028 47,368 (3 Mo. LIBOR + 4.24%), 481,561 25,000 5.013(a)(b) 04/04/2051 32,035 Consumer Services(a) – 0.3% Westpac Banking Corp.(a)(b) Emory University Series 2020 (5 Yr. Swap Rate + 2.24%), 140,000 2.143 09/01/2030 138,316 25,000 4.322 11/23/2031 27,580 McDonald’s Corp. (US Treasury Yield Curve Rate 25,000 4.200 04/01/2050 28,494 T-Note Constant Maturity 5 Yr. + Starbucks Corp. 2.00%), 75,000 3.800 08/15/2025 82,763 25,000 4.110 07/24/2034 26,713 249,573 7,119,565 Electric – 2.2% (a) Capital Goods – 2.2% Alliant Energy Finance LLC(a)(c) Air Lease Corp. 25,000 3.750 06/15/2023 26,574 75,000 2.300 02/01/2025 76,567 American Electric Power Co., Inc.(a) 75,000 3.375 07/01/2025 79,256 50,000 2.300 03/01/2030 48,737 75,000 2.875 01/15/2026 77,624 Arizona Public Service Co.(a) 75,000 3.750 06/01/2026 80,104 45,000 2.950 09/15/2027 48,429 Aviation Capital Group LLC(c) Avangrid, Inc.(a) 50,000 1.950 01/30/2026 48,720 25,000 3.200 04/15/2025 26,794 Boeing Co.
Load more

Recommended publications
  • Ethics Agreement in Order to Avoid Any Financial Conflict
    Date: 7 .-e-•15 Iett..% 1--4 17 MEMORANDUM FOR THE RECORD SUBJECT: Ethics Agreement In order to avoid any financial conflict of interest in violation of 18 U.S.C. § 208(a) or the appearance of a financial conflict of interest as defined in the Standards of Ethical Conduct for Employees of the Executive Branch, 5 C.F.R. § 2635.502, and to adhere to the Ethics Pledge instituted by Executive Order 13770 issued on January 28, 2017, and entitled "Ethics Commitments by Executive Branch Appointees" (the Ethics Pledge), I am issuing the following statement. I understand that as an appointee I must sign the Ethics Pledge and that I will be bound by the requirements and restrictions therein even if not specifically mentioned in this or any other ethics agreement. Before beginning my covered Federal position, I resigned from my non-Federal positions with the Association of State and Territorial Health Officials (ASTHO) and the State of Georgia on July 6, 2017. Pursuant to the Ethics Pledge, I will not, for a period of two years from the date of my appointment to my covered Federal position, participate in an official capacity in any particular matter involving specific parties that is directly and substantially related to ASTHO, unless an exception applies or I am granted a waiver. I understand that this provision in the Ethics Pledge does not apply to state government entities, including the State of Georgia. Even when the two-year restriction of the Ethics Pledge does not apply, under 5 C.F.R. § 2635.502, I will not, for a period of one year from the date of my resignation from ASTHO and the State of Georgia, participate in any particular matter involving specific parties in which ASTHO or the State of Georgia is a party or represents a party, unless I am first authorized to participate, pursuant to 5 C.F.R.
    [Show full text]
  • Investor Presentation May 2, 2018 Notices and Disclaimers
    Investor Presentation May 2, 2018 Notices and Disclaimers Forward-Looking Statements This presentation contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements include certain information concerning future results of operations, business strategies, financing plans, competitive position, potential growth opportunities, potential operating performance improvements, the effects of competition and the effects of future legislation or regulations. Forward-looking statements include all statements that are not historical facts and can be identified by the use of forward-looking terminology such as the words “believe,” “expect,” “plan,” “intend,” “anticipate,” “estimate,” “predict,” “potential,” “continue,” “may,” “might,” “should,” “could” or the negative of these terms or similar expressions. Forward-looking statements involve risks, uncertainties and assumptions. Actual results may differ materially from those expressed in such forward-looking statements. You should not put undue reliance on any forward-looking statements contained herein. PJT Partners undertakes no obligation to publicly update or review any forward-looking statement, whether as a result of new information, future developments or otherwise. The risk factors discussed in the “Risk Factors” section of our Annual Report on Form 10-K for the year ended December 31, 2017, filed with the United States Securities and Exchange Commission (“SEC”), as such factors may be updated from time to time in our periodic filings with the SEC, accessible on the SEC’s website at www.sec.gov, could cause the results of PJT Partners to differ materially from those expressed in forward-looking statements.
    [Show full text]
  • Genmab Announces Data to Be Presented at 2017 ASCO Annual Meeting
    Genmab Announces Data to be Presented at 2017 ASCO Annual Meeting Media Release 8 abstracts on Genmab programs scheduled for presentation at ASCO Two daratumumab oral presentations and five daratumumab poster presentations Copenhagen, Denmark; April 20, 2017 – Genmab A/S (Nasdaq Copenhagen: GEN) announced today that seven daratumumab abstracts have been accepted for presentation at the 2017 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, June 2 – 6. These abstracts, submitted by our collaboration partner, Janssen Biotech, Inc., include updates for the POLLUX and CASTOR trials, and the first data for a Phase I study evaluating daratumumab with carfilzomib, lenalidomide and dexamethasone in front line multiple myeloma patients, which will be presented in an oral presentation. In addition, descriptions of the Phase Ib/II study of daratumumab plus atezolizumab in non-small cell lung cancer and of our Phase I/II study with HuMax-AXL-ADC are scheduled for poster presentations at the meeting. The titles of the abstracts are currently available on the ASCO website with the full abstracts scheduled to be published on May 17, 2017. “We are very pleased that, once again, a number of abstracts based on exciting work with Genmab’s innovative therapeutic antibody products have been accepted for presentation at the prestigious ASCO conference,” said Jan van de Winkel, Ph.D., Chief Executive Officer of Genmab. List of abstracts: Daratumumab: Efficacy Of Daratumumab In Combination with Lenalidomide Plus Dexamethasone (DRd) or
    [Show full text]
  • View Annual Report
    Five trillion dollars of securities trade on NasdaqT. Where will the five trillion dollars of commercial real estate assets trade? Annual Report 1999 www.costargroup.com mission statement Through its products and services, CoStar Group, Inc. offers customers access to the most comprehensive, verified database of real estate infor- mation on the U.S. commercial real estate industry. Today, CoStar is creating the Internet marketplace for commercial real estate by bringing together its extensive database, 700 experienced researchers, technological expertise and a broad customer base comprised of the most active real estate firms trans- acting business in the United States. CoStar’s goal is to improve liquidity and ultimately increase the value of commercial real estate. table of contents Financial Highlights.................Page 1 Letter to Our Shareholders.....Page 2 1999 Form 10K.........................Page 5 financial highlights in thousands except per share data 1997 1998 1999 Revenues . $ 7,900 $13,900 $ 30,234 Net loss . (3,266) (3,185) (12,277) Net loss per share . (0.57) (0.44) (1.05) Weighted average common shares . 5,722 7,213 11,727 Cash and cash equivalents . 1,069 19,667 94,074 Total assets . 6,581 27,541 136,905 Stockholders’ equity . 2,917 23,203 119,697 growth in revenue database markets growth ($ millions) growth (billions of sq. ft.) 50 $35 20 30 40 15 25 30 20 10 15 20 10 5 10 5 0 0 0 ’97 ’98 ’99 ’97 ’98 ’99 ’97 ’98 ’99 1 to our shareholders improved liquidity, resulting in increased valuations for their assets. Just as the Nasdaq, in 1971, provided over-the-counter securities brokers a centralized, digital marketplace, facilitating over 500% growth and escalating market value to $5 trillion today—we believe CoStar is positioned to be the exchange that realizes significant value for the $5 trillion commercial real estate asset class.
    [Show full text]
  • Wilmington Funds Holdings Template DRAFT
    Wilmington Global Alpha Equities Fund as of 5/31/2021 (Portfolio composition is subject to change) ISSUER NAME % OF ASSETS USD/CAD FWD 20210616 00050 3.16% DREYFUS GOVT CASH MGMT-I 2.91% MORGAN STANLEY FUTURE USD SECURED - TOTAL EQUITY 2.81% USD/EUR FWD 20210616 00050 1.69% MICROSOFT CORP 1.62% USD/GBP FWD 20210616 49 1.40% USD/JPY FWD 20210616 00050 1.34% APPLE INC 1.25% AMAZON.COM INC 1.20% ALPHABET INC 1.03% CANADIAN NATIONAL RAILWAY CO 0.99% AIA GROUP LTD 0.98% NOVARTIS AG 0.98% TENCENT HOLDINGS LTD 0.91% INTACT FINANCIAL CORP 0.91% CHARLES SCHWAB CORP/THE 0.91% FACEBOOK INC 0.84% FORTIVE CORP 0.81% BRENNTAG SE 0.77% COPART INC 0.75% CONSTELLATION SOFTWARE INC/CANADA 0.70% UNITEDHEALTH GROUP INC 0.70% AXA SA 0.63% FIDELITY NATIONAL INFORMATION SERVICES INC 0.63% BERKSHIRE HATHAWAY INC 0.62% PFIZER INC 0.62% TOTAL SE 0.61% MEDICAL PROPERTIES TRUST INC 0.61% VINCI SA 0.60% COMPASS GROUP PLC 0.60% KDDI CORP 0.60% BAE SYSTEMS PLC 0.57% MOTOROLA SOLUTIONS INC 0.57% NATIONAL GRID PLC 0.56% PUBLIC STORAGE 0.56% NVR INC 0.53% AMERICAN TOWER CORP 0.53% MEDTRONIC PLC 0.51% PROGRESSIVE CORP/THE 0.50% DANAHER CORP 0.50% MARKEL CORP 0.49% JOHNSON & JOHNSON 0.48% BUREAU VERITAS SA 0.48% NESTLE SA 0.47% MARSH & MCLENNAN COS INC 0.46% ALIBABA GROUP HOLDING LTD 0.45% LOCKHEED MARTIN CORP 0.45% ALPHABET INC 0.44% MERCK & CO INC 0.43% CINTAS CORP 0.42% EXPEDITORS INTERNATIONAL OF WASHINGTON INC 0.41% MCDONALD'S CORP 0.41% RIO TINTO PLC 0.41% IDEX CORP 0.40% DIAGEO PLC 0.40% LENNOX INTERNATIONAL INC 0.40% PNC FINANCIAL SERVICES GROUP INC/THE 0.40% ACCENTURE
    [Show full text]
  • Employment Report
    2019 EMPLOYMENT REPORT Columbia Business School students experience unparalleled access to dynamic companies and leaders After 21 years of teaching at this institution, it is an honor to assume the role of Dean of Columbia Business School. in New York and around the world, I want to thank Dean Glenn Hubbard for his excellent joining an entrepreneurial community stewardship of the School over these last 15 years. that fosters innovation and creates Columbia Business School is ushering in a new generation of students during a critical time—one that demands we everyday impact in the global address the rapidly-evolving needs of business in the digital future. The nature of the MBA job market has changed and so too must business education, which is at an inflection point, marketplace. They build connections where data science is as important as management science. with practitioners and industry This is why we must redefine business education, by sharpening our curriculum in order to embrace how technology, data, and leaders, and tap into a lifetime algorithms are transforming business. We will need to continue to create experiential learning opportunities to better prepare students for careers in the digital future across industries. We network of more than 47,000 alumni must strengthen our engagement with the University, creating curricular opportunities for our students, and exploring spanning over 100 countries who offer collaborative research in areas of broader impact and of significant interest to the School. We must also strengthen mentoring opportunities, internships, faculty thought leadership and enhance lifelong learning by offering new courses to alumni who want to continuously and so much more.
    [Show full text]
  • Genmab's 2020 Capital Markets
    WELCOME Genmab’s 2020 Capital Markets Day November 13, 2020 Webcast Live from Utrecht and Princeton Forward Looking Statement This presentation contains forward looking statements. The words “believe”, “expect”, “anticipate”, “intend” and “plan” and similar expressions identify forward looking statements. All statements other than statements of historical facts included in this presentation, including, without limitation, those regarding our financial position, business strategy, plans and objectives of management for future operations (including development plans and objectives relating to our products), are forward looking statements. Such forward looking statements involve known and unknown risks, uncertainties and other factors which may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by such forward looking statements. Such forward looking statements are based on numerous assumptions regarding our present and future business strategies and the environment in which we will operate in the future. The important factors that could cause our actual results, performance or achievements to differ materially from those in the forward looking statements include, among others, risks associated with product discovery and development, uncertainties related to the outcome of clinical trials, slower than expected rates of patient recruitment, unforeseen safety issues resulting from the administration of our products in patients, uncertainties related to product manufacturing, the lack of market acceptance of our products, our inability to manage growth, the competitive environment in relation to our business area and markets, our inability to attract and retain suitably qualified personnel, the unenforceability or lack of protection of our patents and proprietary rights, our relationships with affiliated entities, changes and developments in technology which may render our products obsolete, and other factors.
    [Show full text]
  • Equinix Inc (Eqix) 10-Q
    EQUINIX INC (EQIX) 10-Q Quarterly report pursuant to sections 13 or 15(d) Filed on 04/27/2012 Filed Period 03/31/2012 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2012 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 000-31293 EQUINIX, INC. (Exact name of registrant as specified in its charter) Delaware 77-0487526 (State of incorporation) (I.R.S. Employer Identification No.) One Lagoon Drive, Fourth Floor, Redwood City, California 94065 (Address of principal executive offices, including ZIP code) (650) 598-6000 (Registrant's telephone number, including area code) Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports) Yes x No ¨ and (2) has been subject to such filing requirements for the past 90 days. Yes x No ¨ Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).
    [Show full text]
  • Interconnection
    Interconnection 101 As cloud usage takes off, data production grows exponentially, content pushes closer to the edge, and end users demand data and applications at all hours from all locations, the ability to connect with a wide variety of players becomes ever more important. This report introduces interconnection, its key players and busi- ness models, and trends that could affect interconnection going forward. KEY FINDINGS Network-dense, interconnection-oriented facilities are not easy to replicate and are typically able to charge higher prices for colocation, as well as charging for cross-connects and, in some cases, access to public Internet exchange platforms and cloud platforms. Competition is increasing, however, and competitors are starting the long process of creating network-dense sites. At the same time, these sites are valuable and are being acquired, so the sector is consolidating. Having facili- ties in multiple markets does seem to provide some competitive advantage, particularly if the facilities are similar in look and feel and customers can monitor them all from a single portal and have them on the same contract. Mobility, the Internet of Things, services such as SaaS and IaaS (cloud), and content delivery all depend on net- work performance. In many cases, a key way to improve network performance is to push content, processing and peering closer to the edge of the Internet. This is likely to drive demand for facilities in smaller markets that offer interconnection options. We also see these trends continuing to drive demand for interconnection facilities in the larger markets as well. © 2015 451 RESEARCH, LLC AND/OR ITS AFFILIATES.
    [Show full text]
  • JPMORGAN TRUST II Form NPORT-P Filed 2021
    SECURITIES AND EXCHANGE COMMISSION FORM NPORT-P Filing Date: 2021-05-26 | Period of Report: 2021-03-31 SEC Accession No. 0001752724-21-111489 (HTML Version on secdatabase.com) FILER JPMORGAN TRUST II Mailing Address Business Address 277 PARK AVENUE 277 PARK AVENUE CIK:763852| IRS No.: 000000000 | State of Incorp.:DE NEW YORK NY 10172 NEW YORK NY 10172 Type: NPORT-P | Act: 40 | File No.: 811-04236 | Film No.: 21962894 800-480-4111 Copyright © 2021 www.secdatabase.com. All Rights Reserved. Please Consider the Environment Before Printing This Document JPMorgan Small Cap Value Fund SCHEDULE OF PORTFOLIO INVESTMENTS AS OF MARCH 31, 2021 (Unaudited) Investments Shares (000) Value ($000) COMMON STOCKS 96.7% Aerospace & Defense 1.1% AAR Corp. * 107 4,473 Astronics Corp. * 208 3,754 Maxar Technologies, Inc. 109 4,111 Moog, Inc., Class A 33 2,711 Triumph Group, Inc. * 45 831 15,880 Air Freight & Logistics 0.5% Echo Global Logistics, Inc. * 223 6,995 Hub Group, Inc., Class A * 6 404 7,399 Airlines 1.1% Allegiant Travel Co. * 19 4,710 Hawaiian Holdings, Inc. * 108 2,891 SkyWest, Inc. * 156 8,499 16,100 Auto Components 1.6% Adient plc * 122 5,392 American Axle & Manufacturing Holdings, Inc. * 48 461 Cooper Tire & Rubber Co. 47 2,653 Dana, Inc. 226 5,495 Gentherm, Inc. * 69 5,084 Goodyear Tire & Rubber Co. (The) * 245 4,306 23,391 Banks 15.6% 1st Source Corp. 59 2,783 American National Bankshares, Inc. 3 109 Atlantic Capital Bancshares, Inc. * 41 998 Atlantic Union Bankshares Corp.
    [Show full text]
  • March 31, 2021
    Units Cost Market Value US Equity Index Fund US Equities 95.82% Domestic Common Stocks 10X GENOMICS INC 126 10,868 24,673 1LIFE HEALTHCARE INC 145 6,151 4,794 2U INC 101 5,298 4,209 3D SYSTEMS CORP 230 5,461 9,193 3M CO 1,076 182,991 213,726 8X8 INC 156 2,204 4,331 A O SMITH CORP 401 17,703 28,896 A10 NETWORKS INC 58 350 653 AAON INC 82 3,107 5,132 AARON'S CO INC/THE 43 636 1,376 ABBOTT LABORATORIES 3,285 156,764 380,830 ABBVIE INC 3,463 250,453 390,072 ABERCROMBIE & FITCH CO 88 2,520 4,086 ABIOMED INC 81 6,829 25,281 ABM INDUSTRIES INC 90 2,579 3,992 ACACIA RESEARCH CORP 105 1,779 710 ACADIA HEALTHCARE CO INC 158 8,583 9,915 ACADIA PHARMACEUTICALS INC 194 6,132 4,732 ACADIA REALTY TRUST 47 1,418 1,032 ACCELERATE DIAGNOSTICS INC 80 1,788 645 ACCELERON PHARMA INC 70 2,571 8,784 ACCO BRANDS CORP 187 1,685 1,614 ACCURAY INC 64 483 289 ACI WORLDWIDE INC 166 3,338 6,165 ACTIVISION BLIZZARD INC 1,394 52,457 133,043 ACUITY BRANDS INC 77 13,124 14,401 ACUSHNET HOLDINGS CORP 130 2,487 6,422 ADAPTHEALTH CORP 394 14,628 10,800 ADAPTIVE BIOTECHNOLOGIES CORP 245 11,342 10,011 ADOBE INC 891 82,407 521,805 ADT INC 117 716 1,262 ADTALEM GLOBAL EDUCATION INC 99 4,475 3,528 ADTRAN INC 102 2,202 2,106 ADVANCE AUTO PARTS INC 36 6,442 7,385 ADVANCED DRAINAGE SYSTEMS INC 116 3,153 13,522 ADVANCED ENERGY INDUSTRIES INC 64 1,704 7,213 ADVANCED MICRO DEVICES INC 2,228 43,435 209,276 ADVERUM BIOTECHNOLOGIES INC 439 8,321 1,537 AECOM 283 12,113 17,920 AERIE PHARMACEUTICALS INC 78 2,709 1,249 AERSALE CORP 2,551 30,599 31,785 AES CORP/THE 1,294 17,534 33,735 AFFILIATED
    [Show full text]
  • Announcement February 22, 2019
    Announcement February 22, 2019 Indxx USA Regional Banking Index will be reconstituted after the close of trading hours on February 28, 2019. Listed below are the constituents that will be added to the existing index: S.No ISIN Company Name 1 US5116561003 Lakeland Financial Corporation 2 US42234Q1022 Heartland Financial USA, Inc. 3 US3369011032 1st Source Corporation 4 US89214P1093 TowneBank 5 US4461501045 Huntington Bancshares Incorporated 6 US1637311028 Chemical Financial Corporation 7 US2298991090 Cullen/Frost Bankers, Inc. 8 US1176651099 Bryn Mawr Bank Corporation 9 US72346Q1040 Pinnacle Financial Partners, Inc. 10 US90539J1097 Union Bankshares Corporation 11 US81768T1088 ServisFirst Bancshares Inc 12 US06652K1034 BankUnited, Inc. 13 US6952631033 PacWest Bancorp 14 US9897011071 Zions Bancorporation, N.A. 15 US05945F1030 BancFirst Corporation 16 US15201P1093 CenterState Bank Corporation Listed below are the constituents that will be deleted from the existing index: S.No ISIN Company Name 1 US03076K1088 Ameris Bancorp 2 US05561Q2012 BOK Financial Corporation 3 US1011191053 Boston Private Financial Holdings, Inc. 4 US1547604090 Central Pacific Financial Corp. 5 US1972361026 Columbia Banking System, Inc. 6 US2937121059 Enterprise Financial Services Corp 7 US3198291078 First Commonwealth Financial Corporation 8 US3202091092 First Financial Bancorp. 9 US3205171057 First Horizon National Corporation 10 US52471Y1064 LegacyTexas Financial Group, Inc. 11 US7838591011 S&T Bancorp, Inc. 12 US8404411097 South State Corporation 13 US84470P1093 Southside Bancshares, Inc. 14 US9027881088 UMB Financial Corporation 15 US9197941076 Valley National Bancorp Listed below are the new index constituents that will be effective at the close of trading hours on February 28, 2019. Weights as of S.No ISIN Company Name Feb 21, 2019 1 US1491501045 Cathay General Bancorp 2.00% 2 US8984021027 Trustmark Corporation 2.00% 3 US4590441030 International Bancshares Corporation 2.00% 4 US1266001056 CVB Financial Corp.
    [Show full text]